Amundi’s Altimmune ALT Stock Holding History

Amundi’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,273	Closed	-$14.6K	–	1671
2025 Q1	$14.6K	Hold	3,273	–	–	﹤0.01%	1869
2024 Q4	$24.4K	Buy	+3,273	New	+$25K	﹤0.01%	1878
2024 Q1	–	Sell	-34,972	Closed	-$410K	–	2000
2023 Q4	$410K	Buy	+34,972	New	+$146K	﹤0.01%	1467

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Amundi's ALT Position: Q2 2025 in Review

Amundi sold out of Altimmune (ALT) in Q2 2025, closing a stake of 3,273 shares — an estimated $14.6K sold.

Amundi first reported a position in ALT in Q4 2023 and held it in 3 quarters. The position peaked at $410K in Q4 2023. 180 funds tracked by Wall St. Rank hold ALT as of Q2 2025.

Amundi reported no remaining Altimmune position as of Q2 2025 after selling out during the quarter.
Amundi sold 3,273 Altimmune shares in Q2 2025, an estimated $14.6K.
Amundi first reported a position in Altimmune in Q4 2023 and held it in 3 quarters.
Amundi's Altimmune position peaked at $410K in Q4 2023.
180 funds tracked by Wall St. Rank held Altimmune as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.